A multivalent nanoparticle vaccine composition suitable for use in an influenza vaccine is disclosed herein.Nanoparticles include an effective amount of influenza glycoprotein that results in increased immune response compared to a commercial influenza vaccine composition.The present disclosure also provides a cost effective and useful vaccine formulation strategy for clinical use.A method of administering a nanoparticle vaccine composition to an object is also disclosed.No selection
展开▼